Key Performance
More- Earnings Score: 59
- Momentum Score: 64
- True Yield: N/A
- Financial Health Score: 74
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
The FDA issued a warning letter to Neogen Corporation on September 29, 2026, following an investigation linking its veterinary wound care product Neogen Vet HYCOAT to at least 20 horse deaths from serious infections. The contaminated sterile solution represents the largest number of horse deaths associated with a quality defect in an FDA-regulated veterinary product. Neogen initiated a voluntary recall in January 2026. The announcement triggered a 7.22% stock price decline. Pomerantz LLP is investigating potential securities fraud claims on behalf of investors.
10/13/2026, 4:52 PM • GlobeNewswire
The global veterinary diagnostics market is projected to grow from USD 11.76 billion in 2025 to USD 30.78 billion by 2035, driven by increasing pet ownership, zoonotic disease surveillance, and advancements in point-of-care testing and molecular diagnostics. North America leads with 39% market share, while Asia-Pacific shows the fastest growth. Reagents & kits dominate products, while companion animals represent 61% of the market.
09/28/2026, 10:00 AM • GlobeNewswire
Why Neogen Stock Blasted More Than 31% Higher Today
Neogen stock surged over 31% after posting a beat-and-raise fiscal Q2 earnings report. Despite revenue declining nearly 3% year-over-year to $224.7 million and net income dropping slightly, the company crushed analyst expectations and raised full-year guidance. However, the analyst expresses caution about the stock's future, noting the revenue decline and suggesting investors may be overexcited about the results.
01/08/2026, 7:04 PM • The Motley Fool
Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education
Neogen Corporation has renewed its sponsorship with US Equestrian, focusing on educational materials about equine botulism prevention and treatment. The collaboration aims to raise awareness about the potentially deadly neurotoxin and promote horse health through scientific resources.
09/25/2025, 5:26 PM • Benzinga
A class action lawsuit has been filed against Neogen Corporation alleging false and misleading statements about company integration and financial performance during the period of January 5, 2023 to June 3, 2025.
09/16/2025, 4:00 PM • GlobeNewswire
Neogen Corporation faces a securities class action lawsuit alleging failure to disclose material information during January 5, 2023 to June 3, 2025, with stock price dropping significantly after revenue and earnings guidance announcements.
09/15/2025, 10:25 PM • GlobeNewswire
Rosen Law Firm alerts Neogen Corporation investors about a September 16, 2025 deadline for a securities class action lawsuit related to allegedly misleading statements about company integration and performance.
09/15/2025, 9:30 PM • GlobeNewswire
Kahn Swick & Foti, LLC alerts investors about a class action lawsuit against Neogen Corporation for allegedly failing to disclose material financial information between January 5, 2023 and June 3, 2025, resulting in significant stock price declines.
09/09/2025, 10:07 PM • GlobeNewswire
A class action lawsuit has been filed against Neogen Corporation alleging misrepresentation of 3M integration status and financial performance, with stock price declining significantly after revealing integration challenges and cutting financial guidance.
09/07/2025, 10:56 AM • GlobeNewswire
Neogen Corporation faces a class action lawsuit alleging false statements about the integration of a former 3M food safety business, with claims of misleading investors about integration progress and margin performance.
09/04/2025, 12:16 PM • Benzinga
Neogen Corporation faces a securities class action lawsuit alleging failure to disclose material information during January 2023 to June 2025, with stock price dropping significantly after revenue and EBITDA margin disclosures.
09/03/2025, 9:06 PM • GlobeNewswire
Law firm alerts investors about potential securities fraud class action lawsuits for multiple companies, highlighting alleged misleading statements and financial misrepresentations across different sectors.
09/03/2025, 12:00 PM • GlobeNewswire
Kahn Swick & Fosti, LLC alerts investors about a class action lawsuit against Neogen Corporation for allegedly failing to disclose material financial information between January 5, 2023 and June 3, 2025, resulting in significant stock price declines.
09/02/2025, 9:37 PM • GlobeNewswire
Rosen Law Firm alerts Neogen Corporation investors who purchased stock between January 5, 2023 and June 3, 2025 about a potential securities class action lawsuit regarding allegedly misleading statements about company integration.
09/01/2025, 6:45 AM • GlobeNewswire
NEOG 周一截止日期：獲評為頂尖、業界領先的律師事務所 ROSEN，呼籲損失超過 10 萬美元的 Neogen Corporation 投資人，在證券集體訴訟的重要截止日前尋求法律意見 – NEOG
Rosen Law Firm is notifying investors who purchased Neogen Corporation stock between January 5, 2023, and June 3, 2025, about a potential securities class action lawsuit alleging false and misleading statements regarding company integration progress.
09/01/2025, 6:45 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 10/21/2026
Company Profile
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.